Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.
Also called NCT03892824
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Javelin Medical
- Registry
-
NCT03892824
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Belgium, Czechia, Germany, Greece, Hungary, Israel, Poland, Spain
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03892824. Allocation not applicable; no masking; primary purpose prevention. Start 2019-04-15 (actual); primary completion 2024-10-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
- Acronym
- CAPTURE2
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Intervention (Device)
- Vine™ Embolic Protection System
- Lead sponsor
- Javelin Medical
- Collaborator
- Genae
Record details
- Record id
cardio:ct-nct03892824- Content hash
fce3de5ddb79c8180c961d4215dab5fe3bde3dd20f9185228a0b6913a5d37dfc